STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma

被引：0
|
作者：
Cosimo Lobello
Boris Tichy
Vojtech Bystry
Lenka Radova
Daniel Filip
Marek Mraz
Ivonne-Aidee Montes-Mojarro
Nina Prokoph
Hugo Larose
Huan-Chang Liang
Geeta G. Sharma
Luca Mologni
David Belada
Katerina Kamaradova
Falko Fend
Carlo Gambacorti-Passerini
Olaf Merkel
Suzanne D. Turner
Andrea Janikova
Sarka Pospisilova
机构：
[1] Masaryk University,Center of Molecular Medicine, Central European Institute of Technology (CEITEC)
[2] University Hospital Brno and Medical Faculty MU,Department of Internal Medicine—Hematology and Oncology
[3] Eberhard Karls University,Institute of Pathology and Neuropathology and Comprehensive Cancer Center Tübingen
[4] University of Cambridge,Division of Cellular and Molecular Pathology, Department of Pathology
[5] Medical University of Vienna,Department of Pathology
[6] University of Milano-Bicocca,Department of Medicine and Surgery
[7] Charles University Hospital and Faculty of Medicine,4th Department of Internal Medicine—Hematology
[8] Charles University Hospital and Faculty of Medicine,Fingerland Department of Pathology
来源：
Leukemia | 2021年 / 35卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1500 / 1505
页数：5
相关论文
共 50 条
  • [31] Isolated TP53 Mutations Portend Worse Prognosis in MDS and AML Compared to TP53 Mutations with Concurrent Myeloid-Associated Mutations
    Hussaini, Mohammad
    Abuel-Haija, Mohammad
    Padron, Eric
    David, Sallman
    Song, Jinming
    LABORATORY INVESTIGATION, 2018, 98 : 524 - 525
  • [32] Isolated TP53 Mutations Portend Worse Prognosis in MDS and AML Compared to TP53 Mutations with Concurrent Myeloid-Associated Mutations
    Hussaini, Mohammad
    Abuel-Haija, Mohammad
    Padron, Eric
    David, Sallman
    Song, Jinming
    MODERN PATHOLOGY, 2018, 31 : 524 - 525
  • [33] β-catenin is constitutively active and increases STAT3 expression/activation in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma
    Anand, Mona
    Lai, Raymond
    Gelebart, Pascal
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (02): : 253 - 261
  • [34] Frequency, Spectrum, and Functional Significance of TP53 Mutations in Patients with Diffuse Large B-Cell Lymphoma
    Voropaeva, E. N.
    Pospelova, T. I.
    Voevoda, M. I.
    Maksimov, V. N.
    MOLECULAR BIOLOGY, 2017, 51 (01) : 53 - 60
  • [35] Frequency, spectrum, and functional significance of TP53 mutations in patients with diffuse large B-cell lymphoma
    E. N. Voropaeva
    T. I. Pospelova
    M. I. Voevoda
    V. N. Maksimov
    Molecular Biology, 2017, 51 : 53 - 60
  • [36] PDGFRβ promotes oncogenic progression via STAT3/STAT5 hyperactivation in anaplastic large cell lymphoma
    I. Garces de los Fayos Alonso
    L. Zujo
    I. Wiest
    P. Kodajova
    G. Timelthaler
    S. Edtmayer
    M. Zrimšek
    S. Kollmann
    C. Giordano
    M. Kothmayer
    H. A. Neubauer
    S. Dey
    M. Schlederer
    B. S. Schmalzbauer
    T. Limberger
    C. Probst
    O. Pusch
    S. Högler
    S. Tangermann
    O. Merkel
    A. I. Schiefer
    C. Kornauth
    N. Prutsch
    M. Zimmerman
    B. Abraham
    J. Anagnostopoulos
    L. Quintanilla-Martinez
    S. Mathas
    P. Wolf
    D. Stoiber
    P. B. Staber
    G. Egger
    W. Klapper
    W. Woessmann
    T. A. Look
    P. Gunning
    S. D. Turner
    R. Moriggl
    S. Lagger
    L. Kenner
    Molecular Cancer, 21
  • [37] PDGFRβ promotes oncogenic progression via STAT3/STAT5 hyperactivation in anaplastic large cell lymphoma
    Alonso, I. Garces de los Fayos
    Zujo, L.
    Wiest, I
    Kodajova, P.
    Timelthaler, G.
    Edtmayer, S.
    Zrimsek, M.
    Kollmann, S.
    Giordano, C.
    Kothmayer, M.
    Neubauer, H. A.
    Dey, S.
    Schlederer, M.
    Schmalzbauer, B. S.
    Limberger, T.
    Probst, C.
    Pusch, O.
    Hogler, S.
    Tangermann, S.
    Merkel, O.
    Schiefer, A., I
    Kornauth, C.
    Prutsch, N.
    Zimmerman, M.
    Abraham, B.
    Anagnostopoulos, J.
    Quintanilla-Martinez, L.
    Mathas, S.
    Wolf, P.
    Stoiber, D.
    Staber, P. B.
    Egger, G.
    Klapper, W.
    Woessmann, W.
    Look, T. A.
    Gunning, P.
    Turner, S. D.
    Moriggl, R.
    Lagger, S.
    Kenner, L.
    MOLECULAR CANCER, 2022, 21 (01)
  • [38] Clinical significance of TP53 mutations in adult T-cell leukemia/lymphoma
    Sakamoto, Yuma
    Ishida, Takashi
    Masaki, Ayako
    Murase, Takayuki
    Takeshita, Morishige
    Muto, Reiji
    Iwasaki, Hiromi
    Ito, Asahi
    Kusumoto, Shigeru
    Nakano, Nobuaki
    Tokunaga, Masahito
    Yonekura, Kentaro
    Tashiro, Yukie
    Iida, Shinsuke
    Utsunomiya, Atae
    Ueda, Ryuzo
    Inagaki, Hiroshi
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 195 (04) : 571 - 584
  • [39] Simultaneous mutations in K-ras and TP53 are indicative of poor prognosis in sporadic colorectal cancer
    González-Aguilera, JJ
    Oliart, S
    Azcoita, MM
    Fernández-Peralta, AM
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2004, 27 (01): : 39 - 45
  • [40] Massively Parallel Sequencing Identifies Recurrent Mutations in TP53 in Thymic Carcinoma Associated with Poor Prognosis
    Moreira, Andre L.
    Won, Helen H.
    McMillan, Robert
    Huang, James
    Riely, Gregory J.
    Ladanyi, Marc
    Berger, Michael F.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (02) : 373 - 380
12345